scholarly journals Cost drivers of locally advanced rectal cancer treatment—An analysis of a leading healthcare insurer

2021 ◽  
Vol 123 (4) ◽  
pp. 1023-1029
Author(s):  
Fabian Grass ◽  
Amit Merchea ◽  
Kellie L. Mathis ◽  
Nitin Mishra ◽  
Herbert Heien ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Cancer Treatment ◽  
Locally Advanced ◽  
Advanced Rectal Cancer ◽  
Locally Advanced Rectal Cancer ◽  
Cost Drivers ◽  
Rectal Cancer Treatment

Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Francesca De Felice ◽  
Daniele Crocetti ◽  
Veronica Maiuri ◽  
Martina Parisi ◽  
Francesco Marampon ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Elderly Patients ◽  
Cancer Treatment ◽  
Treatment Approach ◽  
Locally Advanced ◽  
Advanced Rectal Cancer ◽  
Locally Advanced Rectal Cancer ◽  
Rectal Cancer Treatment

The Role of Capecitabine in Locally Advanced Rectal Cancer Treatment

Drugs ◽  
2012 ◽  
Vol 72 (8) ◽  
pp. 1057-1073 ◽  
Author(s):  
Carlos Fernández-Martos ◽  
Miquel Nogué ◽  
Paloma Cejas ◽  
Víctor Moreno-García ◽  
Ana Hernández Machancoses ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Cancer Treatment ◽  
Locally Advanced ◽  
Advanced Rectal Cancer ◽  
Locally Advanced Rectal Cancer ◽  
Rectal Cancer Treatment

scholarly journals Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis

2021 ◽  
Vol 14 ◽  
pp. 175628482110421
Author(s):  
Francesca De Felice ◽  
Daniele Crocetti ◽  
Niccolò Petrucciani ◽  
Liliana Belgioia ◽  
Paolo Sapienza ◽  
...  
Keyword(s):  
Machine Learning ◽  
Rectal Cancer ◽  
Cancer Treatment ◽  
Bibliometric Analysis ◽  
Locally Advanced ◽  
Neoadjuvant Treatment ◽  
Advanced Rectal Cancer ◽  
The United States ◽  
Locally Advanced Rectal Cancer ◽  
Rectal Cancer Treatment

A bibliometric analysis was performed using a machine learning bibliometric methodology in order to evaluate the research trends in locally advanced rectal cancer treatment between 2000 and 2020. Information regarding publication outputs, countries, institutions, journals, keywords, funding, and citation counts was retrieved from Scopus database. During the search process, a total of 2370 publications were identified. The vast majority of papers originated from the United States of America, reflecting also its research drive in the collaboration network. Neoadjuvant treatment was the topic most studied in the highly cited studies. New keywords, including neoadjuvant chemotherapy, multiparametric magnetic resonance imaging, circulating tumor DNA, and genetic heterogeneity, appeared in the last 2 years. The quantity of publications on locally advanced rectal cancer treatment since 2000 showed an evolving research field. The ‘new’ keywords explain where research is presently heading.

scholarly journals Effect of Carbogen to Chemoradiation in Volume of Rectal Cancer

2020 ◽  
Author(s):  
Christina Hari Nawangsih ◽  
Soehartati Gondhowiardjo ◽  
Sofia Mubarika Haryana ◽  
Soeharyo Hadisaputro ◽  
Catharina Suhart ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Treatment Group ◽  
Tumor Volume ◽  
Standard Treatment ◽  
Locally Advanced ◽  
Advanced Rectal Cancer ◽  
Locally Advanced Rectal Cancer ◽  
Control Group ◽  
Post Test ◽  
Rectal Cancer Treatment

The outcome of inoperable rectal cancer treatment by chemotherapy, radiotherapy, and targeted therapy are still unfavorable. Carbogen is a combination of 98% oxygen and 2% carbon dioxide proven effective as chemoradiosensitizer. The aim of this study is to know the effect of concurrent carbogen and chemoradiotherapy in locally advanced rectal cancer by measuring the shrinkage of the tumor volume. The design of this study was randomized true experimental 2 groups pre and post-test-controlled design. Samples were patients with locally advanced rectal cancer. MRI of the pelvis before and 4-8 weeks after the chemoradiation were examined. A total of 28 subjects were randomized to 14 patients who received concurrent chemoradiation with carbogen (treatment group) and 14 patients chemoradiation (control) The tumor shrinkage in the treatment group (13.08 to 6.08 cm3 ) was significantly higher compared to the control group (18.00 to 12.83 cm3 ). Supplementation of carbogen to standard treatment chemoradiation for locally advanced rectal cancer significantly shrinkage the tumor volume.

scholarly journals Neoadjuvant chemoradiotherapy in rectal cancer

2020 ◽  
Vol 13 (3) ◽  
pp. 329-333 ◽  
Author(s):  
Christoph Reinhold Arnold ◽  
Julian Mangesius ◽  
Robert Jäger ◽  
Ute Ganswindt
Keyword(s):  
Rectal Cancer ◽  
Checkpoint Inhibitors ◽  
Locally Advanced ◽  
Neoadjuvant Chemoradiotherapy ◽  
Advanced Rectal Cancer ◽  
Short Review ◽  
Locally Advanced Rectal Cancer ◽  
Short Course ◽  
Rectal Cancer Treatment ◽  
Total Neoadjuvant Therapy

Summary Neoadjuvant chemoradiotherapy is a well-established standard treatment for locally advanced rectal cancer and has led to a remarkable improvement in local control. However, distant recurrences still pose a notable threat and local failure, albeit increasingly rare, can lead to unfavorable clinical situations. In this short review, we discuss three promising new strategies to improve rectal cancer treatment: total neoadjuvant therapy, short course radiotherapy, and immune checkpoint inhibitors.

Sign in / Sign up

Export Citation Format

Share Document